Matches in Nanopublications for { ?s ?p "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176961.RAmIBXbx48FhA1E5ME2wREjGW6fS7eeHnkGu3HevFk90s130_provenance.
- assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP931679.RABkbC54fiFR0kOo8AEeJrjGGvwSW639Vao2JVnuHiwm8130_assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931679.RABkbC54fiFR0kOo8AEeJrjGGvwSW639Vao2JVnuHiwm8130_provenance.
- NP391979.RAN8fNpedp3EaIPEx__yCMSus1Z1mX9DRb3Z_99wYPnQw130_assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391979.RAN8fNpedp3EaIPEx__yCMSus1Z1mX9DRb3Z_99wYPnQw130_provenance.
- NP872848.RAMAdzWLGUqulpXcT8fizQWD34YBJVmYHS1k0bB6UHas0130_assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872848.RAMAdzWLGUqulpXcT8fizQWD34YBJVmYHS1k0bB6UHas0130_provenance.
- NP872849.RANegJGCr2C9tQsEOYuMOq65HYatW0zajsqbl-VWlgeSE130_assertion description "[Catalytic domain variants of activated factor VII (FVIIa) with enhanced hemostatic properties are highly attractive for the treatment of bleeding disorders via gene-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872849.RANegJGCr2C9tQsEOYuMOq65HYatW0zajsqbl-VWlgeSE130_provenance.